Recurrent glioblastoma of childhood treated with bevacizumab: case report and molecular features

Introduction Childhood glioblastoma multiforme (GBM) is uncommon, accounting for 7.2% of the central nervous system tumors in childhood. Their clinical behaviors are almost as aggressive as those in adults, and the 5-year overall survival rate is poor.